Linked from

The 35 pages that link to Beta-lactam antibiotic, each with the reason it gives.

• PeptidoglycanRelated: They weaken growing walls by blocking penicillin-binding protein transpeptidases.

• Gram-positive bacteriaRelated: Their targets build peptidoglycan, making wall biology central to their activity.

• Bacterial cell wallRelated: They weaken peptidoglycan construction, especially in actively growing bacteria.

• Penicillin-binding proteinsRelated: They acylate susceptible penicillin-binding proteins and block peptidoglycan cross-linking.

• VancomycinCompared with: They attack a different step in wall construction and remain preferred when the pathogen is susceptible.

• Methicillin-resistant Staphylococcus aureusNarrower topic: Methicillin belongs to this drug family, most of which MRSA resists.

• Beta-lactam ringRelated: The ring is the shared structural feature behind this antibiotic family.

• SulfonamideCompared with: They attack a different bacterial target and became major alternatives to sulfonamide therapy.

• LysozymeCompared with: They prevent peptidoglycan assembly rather than enzymatically cutting existing sugar chains.

• CeftriaxoneNarrower topic: Ceftriaxone belongs to this family and shares its cell-wall target.

• Howard FloreyNarrower topic: Penicillin became the founding member of this broader antibiotic class.

• MycoplasmaCompared with: Their target is absent in Mycoplasma, making the genus intrinsically insusceptible to this drug class.

• Protein synthesis inhibitorCompared with: Beta-lactams attack cell-wall construction rather than ribosomal protein production.

• FluoroquinoloneCompared with: Beta-lactams attack cell-wall construction rather than DNA topology.

• Penicillin allergyNarrower topic: A penicillin allergy label can affect choices across this clinically important drug family.

• Bacterial cell envelopeRelated: They weaken the wall by blocking a central step in its construction.

• Penicillin GBroader topic: This ring is the reactive structural feature that lets Penicillin G inhibit its targets.

• Antibiotic eraBroader topic: This major drug family illustrates how antibiotics exploit structures absent from human cells.

• CefazolinNarrower topic: Cefazolin belongs to this family and shares its cell-wall-targeting action.

• Mycoplasma pneumoniaeCompared with: Without a cell wall, M. pneumoniae is intrinsically unaffected by beta-lactams.

• AztreonamBroader topic: This ring is the defining structural feature of aztreonam and its antibiotic family.

• Clavulanic acidNarrower topic: Clavulanic acid was developed as an adjunct to protect members of this antibiotic family.

• FlucloxacillinNarrower topic: Flucloxacillin belongs to this drug family and shares its core antibacterial mechanism.

• MethicillinNarrower topic: Methicillin belongs to this broad drug family.

• Tetracycline antibioticsCompared with: They attack cell-wall construction rather than protein synthesis and are generally bactericidal.

• AmikacinCompared with: They attack a different bacterial target and are often combined with amikacin in severe infections.

• CefotaximeNarrower topic: Cefotaxime belongs to this broad family and shares its core antibacterial mechanism.

• Staphylococcal infectionCompared with: Many S. aureus strains resist common beta-lactams, while susceptible strains can be treated with them.

• AmpicillinNarrower topic: Ampicillin belongs to this broad drug family and shares its central mechanism.

• CefalexinNarrower topic: Cefalexin belongs to this antibiotic class and shares its cell-wall target.

• CefuroximeNarrower topic: Cefuroxime belongs to this broad drug family.

• CloxacillinNarrower topic: Cloxacillin belongs to this family and acts through its cell-wall-targeting chemistry.

• FosfomycinCompared with: Unlike beta-lactams, fosfomycin blocks precursor formation before the cross-linking stage.

• MeropenemNarrower topic: Meropenem belongs to this large antibiotic family.

• PhenoxymethylpenicillinBroader topic: This ring is the reactive part of penicillin V that inhibits cell-wall enzymes.